The Technical AnalystExchange: OSE Sector: Healthcare Industry: Drug Manufacturers—Specialty & Generic
Aker BioMarine AS Price, Forecast, Insider, Ratings, Fundamentals & Signals
Current Signal: SELL (auto-tracking)
0.14% NOK70.20
Europe/Oslo / 30 apr 2024 @ 16:25
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 6 154.62 mill |
| EPS: | 0.330 |
| P/E: | 212.73 |
| Earnings Date: | Apr 25, 2024 |
| SharesOutstanding: | 87.67 mill |
| Avg Daily Volume: | 0.0490 mill |
| RATING 2024-04-30 |
|---|
| B+ |
| Neutral |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Sell | |
| Return On Equity: | Neutral | |
| Return On Asset: | Neutral | |
| DE: | Strong Buy | |
| P/E: | Neutral | |
| Price To Book: | Sell |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | 1/24 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 3.69x |
| Company: PE 212.73 | sector: PE 57.61 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 1.29x |
| Company: PE 212.73 | industry: PE 165.19 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
NOK 67.69 - 72.71 ( +/- 3.58%) |
| ATR Model: 14 days |
Live Trading Signals (every 1 min)
-10.00
Sell
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | NOK70.20 (0.14% ) |
| Volume | 0.0445 mill |
| Avg. Vol. | 0.0490 mill |
| % of Avg. Vol | 90.85 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For AKBM.OL
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % | Feb 8 - 13:58 | sell | NOK43.05 | N/A | Active |
|---|
AKBM.OL
Aker BioMarine AS develops, produces, and sells krill-derived ingredients for nutraceutical, dietary supplement, and animal feed applications in Norway, the Americas, the Asia Pacific, Europe, the Middle East, and Africa. It operates through two segments, Ingredients and Brands. It provides Superba, a krill-based ingredients for nutraceutical, including phospholipid complex of choline, omega-3s, and antioxidant astaxanthin; QRILL Aqua, a krill-based ingredients for aquaculture; and QRILL Pet, a krill-based ingredients animal feed application. The company also offers LYSOVETA, a delivery platform based on LPC-bound EPA and DHA from krill; and INVI, a hydrolyzed protein isolate for food and beverage applications. In addition, it distributes human health and nutrition products, and natural supplements, as well as provides AION, a circular solution provider that recycles waste and re-use materials. The company was founded in 2006 and is headquartered in Lysaker, Norway. Aker BioMarine ASA is a subsidiary of Aker ASA.